 | Up a level |
Rathore , Yogesh and Shukla , Jaya and Laroiya, Ishita and Deep , Amar and Lakhanpal , Tamanna and Kumar , Rajender and Singh , Harmandeep and Bal, Amanjit and Singh , Gurpreet and Thakur , Krishan Gopal and Mittal , B R (2022) Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patients. Nuclear Medicine Communications , 43 (4). pp. 458-467.
Rathore, Yogendra S and Shukla, Jinal and Mittal, BR and Singh, G and Gopal, K. and Kumar, R and Bal, Amanjit and Laroiya, I and Lakhanpal, T (2021) Radiolabelled trastuzumab Fab as a theranostic molecule for HER2 positive breast cancers. ANNALS OF ONCOLOGY, 32 (2).
